Potentiation of carbon monoxide-induced relaxation of rat aorta by YC-1 [3-(5'-hydroxytmethyl-2'-furyl)-1-benzylindazole]

Canadian Journal of Physiology and Pharmacology

Volumn 78, Issue 4, 2000, Pages 343-349

  McLaughlin, Brian E ^a   Chretien, Marc L ^a   Choi, Christine ^a   Brien, James F ^a   Nakatsu, Kanji ^a   Marks, Gerald S ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Carbon monoxide; Gas chromatographic analysis; Rat aorta; Vasodilation; YC 1 3 (5' hydroxymethyl 2' furyl) 1 benzylindazole

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CARBON MONOXIDE;

ANIMAL TISSUE; AORTA; ARTICLE; GAS CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0034012869     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-145     Document Type: Article

References (43)

1. Brian, J.E., Jr., Heistad, D.D., and Faraci, F.M. 1994. Effect of carbon monoxide on rabbit cerebral arteries. Stroke, 25: 639-644.
2. Burstyn, J.N., Yu, A.E., Dierks, E.A., Hawkins, B.K., and Dawson, J.H. 1995. Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme. Biochemistry, 34: 5896-5903.
3. Christodoulides, N., Durante, W., Kroll, M.H., and Schafer, A.I. 1995. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation, 91: 2306-2309.
4. Coceani, F., Kelsey, L., and Seidlitz, E. 1996. Carbon monoxide-induced relaxation of the ductus arteriosus in the lamb: evidence against the prime role of guanylyl cyclase. Br. J. Pharmacol. 118: 1689-1696.
5. Coceani, F., Kelsey, L., Seidlitz, E., Marks, G.S., McLaughlin, B.E., Vreman, H.J., Stevenson, D.K., Rabinovitch, M., and Ackerley, C. 1997. Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. Br. J. Pharmacol. 120: 599-608.
6. Cook, M.N., Nakatsu, K., Marks, G.S., McLaughlin, B.E., Vreman, H.J., Stevenson, D.K., and Brien, J.F. 1995. Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. Can. J. Physiol. Pharmacol. 73: 515-518.
7. Cook, M.N., Marks, G.S., Vreman, H.J., Nakatsu, K., Stevenson, D.K., and Brien, J.F. 1996. Ontogeny of heme oxygenase activity in the hippocampus, frontal cerebral cortex, and cerebellum of the guinea pig. Dev. Brain Res. 92:18-23.
8. Durante, W., and Schafer, A.I. 1998. Carbon monoxide and vascular cell function (Review). Int. J. Mol. Med. 2: 255-262.
9. Ewing, J.F., Vulapalli, S.R., and Maines, M.D. 1994. Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3′:5′-guanosine monophosphate. J. Pharmacol. Exp. Ther. 271: 408-414.
10. Friebe, A., and Koesling, D. 1998. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53: 123-127.
11. Friebe, A., Schultz, G., and Koesling, D. 1996. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J. 15: 6863-6868.
12. Friebe, A., Müllershausen, F., Smolenski, A., Walter, U., Schultz, G., and Koesling, D. 1998. YC-1 potentiates nitric oxide-and carbon monoxide-induced cyclic GMP effects in human platelets. Mol. Pharmacol. 54: 962-967.
13. Furchgott, R.F., and Jothianandan, D. 1991. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels, 28: 52-61.
14. Galle, J., Zabel, U., Hübner, U., Hatzelmann, A., Wagner, B., Wanner, C., and Schmidt, H.H.H.W. 1999. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br. J. Pharmacol. 127: 195-203.
15. Garthwaite, J., Southam, E., Boulton, C.L., Nielsen, E.B., Schmidt, K., and Mayer, B. 1995. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48: 184-188.
16. Gevantman, L.H. 1998. Solubility of selected gases in water. In CRC handbook of chemistry and physics. Edited by D.R. Lide. CRC Press, New York. pp. 86-89.
17. Gräser, T., Vedernikov, Y.P., and Li, D.S. 1990. Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. Biomed. Biochim. Acta, 49: 293-296.
18. Grundemar, L., Johansson, M.-B., Ekelund, M., and Högestätt, E.D. 1995. Haem oxygenase activity in blood vessel homogenates as measured by carbon monoxide production. Acta Physiol. Scand. 153: 203-204.
19. Hussain, A.S., Marks, G.S., Brien, J.F., and Nakatsu, K. 1997. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can. J. Physiol. Pharmacol. 75: 1034-1037.
20. Johnson, R.A., Kozma, F., and Colombari, E. 1999. Carbon monoxide: from toxin to endogenous modulator of cardiovascular functions. Braz. J. Med. Biol. Res. 32:1-14.
21. Kozma, F., Johnson, R.A., Zhang, F., Yu, C., Tong, X., and Nasjletti, A. 1999. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am. J. Physiol. 276: R1087-R1094.
22. Leffler, C.W., Nasjletti, A., Yu, C., Johnson, R.A., Fedinec, A.L., and Walker, N. 1999. Carbon monoxide and cerebral microvascular tone in newborn pigs. Am. J. Physiol. 276: H1641-H1646.
23. Maines, M.D. 1992. Heme oxygenase: clinical applications and functions. CRC Press, Boca Raton, Fla. 276 pp.
24. Marks, G.S., Brien, J.F., Nakatsu, K., and McLaughlin, B.E. 1991. Does carbon monoxide have a physiological function? Trends Pharmacol. Sci. 12: 185-188.
25. Marks, G.S., McLaughlin, B.E., Vreman, H.J., Stevenson, D.K., Nakatsu, K., Brien, J.F., and Pang, S.C. 1997. Heme oxygenase activity and immunohistochemical localization in bovine pulmonary artery and vein. J. Cardiovasc. Pharmacol. 30: 1-6.
26. McCoubrey, W.K., Jr., Huang, T.J., and Maines, M.D. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247: 725-732.
27. Moncada, S., Palmer, R.M.J., Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142.
28. Morita, T., Perrella, M.A., Lee, M.-E., and Kourembanas, S. 1995. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl. Acad. Sci. U.S.A. 92: 1475-1479.
29. Mülsch, A., Bauersachs, J., Schäfer, A., Stasch, J.-P., Kast, R., and Busse, R. 1997. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol. 120: 681-689.
30. Odrcich, M.J., Graham, C.H., Kimura, K.A., McLaughlin, B.E., Marks, G.S., Nakatsu, K., and Brien, J.F. 1998. Heme oxygenase and nitric oxide synthase in the placenta of the guinea-pig during gestation. Placenta, 19: 509-516.
31. Perry, W.L.M. 1968. Pharmacological Experiments on Isolated Preparations. E. and S. Livingstone Ltd., Edinburgh, p.120.
32. Rodgers, P.A., Vreman, H.J., Dennery, P.A., and Stevenson, D.K. 1994. Sources of carbon monoxide (CO) in biological systems and applications of CO detection technologies. Semin. Perinatol. 18: 2-10.
33. Sammut, I.A., Foresti, R., Clark, J.E., Exon, D.J., Vesely, M.J.J., Sarathchandra, P., Green, C.J., and Motterlini, R. 1999. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br. J. Pharmacol. 125: 1437-1444.
34. Sharma, V.S., Magde, D., Kharitonov, V.G., and Koesling, D. 1999. Soluble guanylate cyclase: effect of YC-1 on ligation kinetics with carbon monoxide. Biochem. Biophys. Res. Commun. 254: 188-191.
35. Siow, R.C.M., Ishii, T., Sato, H., Taketani, S., Leake, D.S., Sweiry, J.H., Pearson, J.D., Bannai, S., and Mann, G.E. 1995. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidized LDL in cultured vascular smooth muscle cells. FEBS Lett. 368: 239-242.
36. Stone, J.R., and Marletta, M.A. 1994. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry, 33: 5636-5640.
37. Stone, J.R., and Marletta, M.A. 1998. Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem. Biol. 5: 255-261.
38. Vreman, H.J., and Stevenson, D.K. 1988. Heme oxygenase activity as measured by carbon monoxide production. Anal. Biochem. 168: 31-38.
39. Wang, R. 1998. Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor. Can. J. Physiol. Pharmacol. 76: 1-15.
40. Wang, R., Wang, Z., and Wu, L. 1997. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br. J. Pharmacol. 121: 927-934.
41. Wegener, J.W., Gath, I., Förstermann, U., and Nawrath, H. 1997. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Br. J. Pharmacol. 122: 1523-1529.
42. Zakhary, R., Gaine, S.P., Dinerman, J.L., Ruat, M., Flavahan, N.A., and Snyder, S.H. 1996. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc. Natl. Acad. Sci. U.S.A. 93: 795-798.
43. Zivin, J.A., and Bartko, J.J. 1976. Statistics for disinterested scientists. Life Sci. 18: 15-26.